Biotechnology

New Blood Test Identifies Metabolic Subtypes Linked to Autism Spectrum Disorder

NeuroPointDX announced the availability of the NPDX AA test, the first objective blood test that identifies metabolic subtypes associated with autism spectrum disorder in children as young as 18 months old. The NPDX AA test works by detecting amine imbalances in a child’s fasting blood sample with very precise thresholds that were identified and validated based […]